{{Rsnum
|rsid=4986907
|Gene=CYP3A4
|Chromosome=7
|position=99769804
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.004132
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CYP3A4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs4986907]], also known as 485G>A, 14269G>A or R162Q, is a SNP in the [[CYP3A4]] gene.

The [[rs4986907]](A) allele defines the CYP3A4*15A variant.

{{PharmGKB
|RSID=rs4986907
|Name_s=CYP3A4:R162Q; CYP3A4:589G>A; CYP3A4*15A; CYP3A4:Arg162Gln
|Gene_s=CYP3A4, CYP3A
|Feature=Exon/NonSyn, Intron
|Evidence=Web Resource:http://www.pharmgkb.org/search/annotatedGene/cyp3a4/haplotype.jsp#ImportantHaplotypeInformationforCYP3A4-21
|Annotation=Defining variant for CYP3A4*15A.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=In-Depth
|PharmGKB Accession ID=PA161145185
}}

{{PMID Auto
|PMID=17615053
|Title=Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}